Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction.
Regen Ther
; 9: 79-88, 2018 Dec.
Article
en En
| MEDLINE
| ID: mdl-30525078
ANP, atrial natriuretic peptide; ARB, angiotensin receptor blocker; ASC, adipose-derived stem cell; AT1(2)R, angiotensin II receptor type 1(2); Adipose-derived stem cell sheet; Angiotensin II; CRT, cardiac resynchronization therapy; EF, ejection fraction; FGF, fibroblast growth factor; FS, fractional shortening; HGF, hepatocyte growth factor; Irbesartan; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; MI, myocardial infarction; MSC, mesenchymal stem cell; Myocardial infarction; RAS, reninangiotensin system; VEGF; VEGF, vascular endothelial growth factor; vWF, von Willebrand factor
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Regen Ther
Año:
2018
Tipo del documento:
Article
País de afiliación:
Japón
Pais de publicación:
Países Bajos